Genpact LTD — fact timeline

Genpact LTD reported first quarter ended March 31, 2026 results: revenue $1.296 billion, net income $148 million, EPS $0.86.

“Net revenues were $1.296 billion, up 6.7% year-over-year, and 5.6% on a constant currency basis.”

Genpact LTD incurred senior notes of $350 million aggregate principal amount with underwriters at 4.950% per annum maturing November 18, 2030.

“completed their previously announced underwritten public offering (the “Notes Offering”) of $350 million aggregate principal amount of their 4.950% Senior Notes due 2030 (the “2030 Notes”).”

Nicholas Gangestad was appointed as Director at Genpact LTD.

“On August 5, 2024, Genpact Limited, a Bermuda company (the “Company”), announced that its Board of Directors (the “Board”) has appointed Nicholas Gangestad to the Board, effective August 12, 2024.”

Genpact LTD reported second quarter of 2024 results: revenue $1.143 billion to $1.148 billion. Guidance initiated.

“Total revenue in the range of $1.143 billion to $1.148 billion, representing year-over-year growth of approximately 3.4% to 3.8% as reported, or 3.6% to 4.0% on a constant currency basis.”

Genpact LTD reported full year 2024 results: revenue $4.59 billion to $4.63 billion, EPS $3.01 to $3.04. Guidance raised.

“Total revenue in the range of $4.59 billion to $4.63 billion, representing year-over-year growth of approximately 2.5% to 3.5% as reported, or 2.7% to 3.7% on a constant currency basis, 1 up from the prior guidance of approximately 2.0% to 3.0% as reported.”

Genpact LTD reported first quarter ended March 31, 2024 results: revenue $1.13 billion, net income $117 million, EPS $0.64.

“Total Revenue of $1.13 billion, Up 4% 1,2,3 Diluted EPS of $0.64, Up 12%; Adjusted Diluted EPS 4 of $0.73, Up 7%”